Completing data — refresh the page later to see the latest
6975-75-3COc1ccc(N=Nc2c(N)n[nH]c2N)cc1QNRNTYHAOBVOKW-BUHFOSPRSA-N6975-75-3DTXSID60415318CHEMBL1389127、CHEMBL1765295、CHEMBL4296845Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
UsesILK-IN-3 is an orally active integrin linked kinase (ILK) inhibitor. ILK-IN-3 improves the anticancer efficacy of Docetaxel (HY-B0011) in orthotopic LCC6 model[1][2].